Indication
Epidermal Growth Factor
1 clinical trial
1 product
Clinical trial
Efficacy and Safety Evaluation of the Intralesional Recombinant Human Epidermal Growth Factor (rhEGF) in Subjects With Diabetic Foot Ulcer. Multicenter, Randomized, Double-blind, Placebo-controlled Study.Status: Active (not recruiting), Estimated PCD: 2019-12-01